美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA217442"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
43602-307-60 43602-307 HUMAN PRESCRIPTION DRUG LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA217442 Ascent Pharmaceuticals, Inc. LISDEXAMFETAMINE DIMESYLATE 20 mg/1 60 CAPSULE in 1 BOTTLE (43602-307-60)
43602-307-05 43602-307 HUMAN PRESCRIPTION DRUG LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA217442 Ascent Pharmaceuticals, Inc. LISDEXAMFETAMINE DIMESYLATE 20 mg/1 500 CAPSULE in 1 BOTTLE (43602-307-05)
43602-306-01 43602-306 HUMAN PRESCRIPTION DRUG LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA217442 Ascent Pharmaceuticals, Inc. LISDEXAMFETAMINE DIMESYLATE 10 mg/1 100 CAPSULE in 1 BOTTLE (43602-306-01)
43602-309-60 43602-309 HUMAN PRESCRIPTION DRUG LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA217442 Ascent Pharmaceuticals, Inc. LISDEXAMFETAMINE DIMESYLATE 40 mg/1 60 CAPSULE in 1 BOTTLE (43602-309-60)
43602-310-05 43602-310 HUMAN PRESCRIPTION DRUG LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA217442 Ascent Pharmaceuticals, Inc. LISDEXAMFETAMINE DIMESYLATE 50 mg/1 500 CAPSULE in 1 BOTTLE (43602-310-05)
43602-310-60 43602-310 HUMAN PRESCRIPTION DRUG LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA217442 Ascent Pharmaceuticals, Inc. LISDEXAMFETAMINE DIMESYLATE 50 mg/1 60 CAPSULE in 1 BOTTLE (43602-310-60)
43602-311-05 43602-311 HUMAN PRESCRIPTION DRUG LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA217442 Ascent Pharmaceuticals, Inc. LISDEXAMFETAMINE DIMESYLATE 60 mg/1 500 CAPSULE in 1 BOTTLE (43602-311-05)
43602-311-60 43602-311 HUMAN PRESCRIPTION DRUG LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA217442 Ascent Pharmaceuticals, Inc. LISDEXAMFETAMINE DIMESYLATE 60 mg/1 60 CAPSULE in 1 BOTTLE (43602-311-60)
43602-312-05 43602-312 HUMAN PRESCRIPTION DRUG LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA217442 Ascent Pharmaceuticals, Inc. LISDEXAMFETAMINE DIMESYLATE 70 mg/1 500 CAPSULE in 1 BOTTLE (43602-312-05)
43602-312-60 43602-312 HUMAN PRESCRIPTION DRUG LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA217442 Ascent Pharmaceuticals, Inc. LISDEXAMFETAMINE DIMESYLATE 70 mg/1 60 CAPSULE in 1 BOTTLE (43602-312-60)
43602-308-60 43602-308 HUMAN PRESCRIPTION DRUG LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA217442 Ascent Pharmaceuticals, Inc. LISDEXAMFETAMINE DIMESYLATE 30 mg/1 60 CAPSULE in 1 BOTTLE (43602-308-60)
43602-308-05 43602-308 HUMAN PRESCRIPTION DRUG LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA217442 Ascent Pharmaceuticals, Inc. LISDEXAMFETAMINE DIMESYLATE 30 mg/1 500 CAPSULE in 1 BOTTLE (43602-308-05)
43602-309-05 43602-309 HUMAN PRESCRIPTION DRUG LISDEXAMFETAMINE DIMESYLATE Lisdexamfetamine dimesylate CAPSULE ORAL 20230825 N/A ANDA ANDA217442 Ascent Pharmaceuticals, Inc. LISDEXAMFETAMINE DIMESYLATE 40 mg/1 500 CAPSULE in 1 BOTTLE (43602-309-05)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase